Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PAVmed Inc. Director's Dealing 2016

May 27, 2016

35221_dirs_2016-05-27_b377bcc4-571a-403a-82d6-b08ecc346bfc.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PAVmed Inc. (PAVM)
CIK: 0001624326
Period of Report: 2016-05-25

Reporting Person: Fitzgerald Richard F (CFO and Secretary)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-05-25 Common Stock P 100 Acquired 100 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-05-25 Warrants $5.00 A 100 Acquired 2022-01-29 Common Stock (100) Indirect

Footnotes

F1: Represents securities included within units, each unit comprised of one share of common stock and one warrant. Each warrant entitles the holder to purchase one share of the issuer's common stcok at an exercise price of $5.00 per share, subject to adjustment.

F2: The units were purchased at a price of $9.75 per unit.